Showing results (311-320 of 1,479) with videos related to

Sort By:
Pageof 148
Human Psychopharmacology|February 3, 2015
The impact of chronic benzodiazepine use on cognitive evolution in nursing home residentsJolyce Bourgeois, Monique M Elseviers, Luc Van Bortel, et al.
Human Psychopharmacology|August 4, 2012
Use of cannabis enhances attentional inhibitionAna B Vivas, Angeles F Estevez, Margarita Moreno, et al.
Human Psychopharmacology|June 15, 2012
Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological basesCecilie L Licht, Maria Christoffersen, Mads Okholm, et al.
Human Psychopharmacology|April 26, 2021
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging studyStephen J Kish, Gerald O'Leary, Mortimer Mamelak, et al.
Human Psychopharmacology|April 15, 2021
The type 2 diabetes mellitus susceptibility gene CDKAL1 polymorphism is associated with depressive symptom in first-episode drug-naive schizophrenic patientsXu Yuan Yin, Peng Chen, Hai Wen Zhu, et al.
Human Psychopharmacology|May 17, 2023
Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo-controlled studyCarlie Abbott-Imboden, Yadira Gonzalez, Andrea Utley
Human Psychopharmacology|January 8, 2014
Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trialsConsuelo García-Gea, Joan Martínez, Maria Rosa Ballester, et al.
Human Psychopharmacology|September 25, 2012
Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysisKeith R Laws, Hilary Sweetnam, Tejinder K Kondel
Human Psychopharmacology|February 20, 2015
Association of angiotensin-converting enzyme gene polymorphism with schizophrenia and depressive symptom severity in a Chinese populationLi Hui, Jing Qin Wu, Min Jie Ye, et al.
Human Psychopharmacology|July 31, 2020
The effect of cannabidiol on simulated car driving performance: A randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocolDanielle McCartney, Melissa J Benson, Anastasia S Suraev, et al.
Pageof 148